Drug intelligence / Profile preview

connective tissue graft

Development stage: Unknown
Lead developer: Shaimaa Hamdy
Administration: Surgical Implantation

Overview

Connective tissue graft (CTG) is an autologous biological tissue used in periodontal plastic surgery to reconstruct deficient interdental papilla. The procedure involves harvesting a layer of subepithelial connective tissue, typically from the patient's palate, and surgically placing it into the site of the papillary defect. The graft acts as a physical scaffold and provides biological cues to support the regeneration and augmentation of the gingival tissue, aiming to eliminate "black triangles" and improve esthetic and functional outcomes. In the clinical trial led by Shaimaa Hamdy, CTG is being compared to Albumin-Platelet Rich Fibrin (Alb-PRF) for its efficacy in rebuilding interdental papilla.

Other names: CTGsubepithelial connective tissue graft

Beyond the preview

Go deeper on connective tissue graft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on connective tissue graft.

Explore the full profile